Agilent

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Agilent and other ETFs, options, and stocks.

About A

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Diagnostics Markets, Applied Markets, and Agilent CrossLab. 

CEO
Padraig Mcdonnell
CEOPadraig Mcdonnell
Employees
18,100
Employees18,100
Headquarters
Santa Clara, California
HeadquartersSanta Clara, California
Founded
1999
Founded1999
Employees
18,100
Employees18,100

A Key Statistics

Market cap
48.37B
Market cap48.37B
Price-Earnings ratio
33.79
Price-Earnings ratio33.79
Dividend yield
0.59%
Dividend yield0.59%
Average volume
2.12M
Average volume2.12M
High today
$172.74
High today$172.74
Low today
$169.90
Low today$169.90
Open price
$171.68
Open price$171.68
Volume
1.54M
Volume1.54M
52 Week high
$177.05
52 Week high$177.05
52 Week low
$108.35
52 Week low$108.35

Stock Snapshot

As of today, Agilent(A) shares are valued at $172.00. The company's market cap stands at 48.37B, with a P/E ratio of 33.79 and a dividend yield of 0.59%.

On 2026-10-14, Agilent(A) stock moved within a range of $169.90 to $172.74. With shares now at $172.00, the stock is trading +1.2% above its intraday low and -0.4% below the session's peak.

Trading volume for Agilent(A) stock has reached 1.54M, versus its average volume of 2.12M.

The stock's 52-week range extends from a low of $108.35 to a high of $177.05.

The stock's 52-week range extends from a low of $108.35 to a high of $177.05.

A News

Reuters 16h
Agilent to buy pathology software maker Proscia for $240 million - Reuters

...

Agilent to buy pathology software maker Proscia for $240 million - Reuters
TipRanks 2d
Agilent price target raised to $190 from $175 at Morgan Stanley

Morgan Stanley raised the firm’s price target on Agilent (A) to $190 from $175 and keeps an Overweight rating on the shares as the firm refreshed models in its...

TipRanks 2d
Transcenta Bolsters Claudin18.2 IP With New China Patent Backing Global Osemitamab Push

Transcenta Holding Limited ( (HK:6628) ) has provided an announcement. Transcenta Holding Limited has strengthened its intellectual property portfolio around i...

Analyst ratings

68%

of 25 ratings
Buy
68%
Hold
32%
Sell
0%

More A News

Simply Wall St 2d
Should New Lab Automation Tools Require Action From Agilent Shares Investors?

Agilent Technologies has recently rolled out the NovoStation Sample Preparation System for automated flow cytometry workflows and the BioTek Gen5 AI cell identi...

Should New Lab Automation Tools Require Action From Agilent Shares Investors?

People also own

Based on the portfolios of people who own A. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.